CoreBiome Bolsters Its Board of Directors with the Addition of Daniel Pomp, Ph.D.

ST. PAUL, Minn.–(BUSINESS WIRE)–CoreBiome, a
genomics platform company that is transforming microbiome innovation
with proprietary laboratory methods and big-data analytics, today
announced the appointment of Dr. Daniel Pomp, Ph.D., a world leader in
agricultural and biomedical genomics, to its Board of Directors.

Daniel Pomp has over 30 years of experience in the biomedical genomics
and agricultural biotechnology spaces. Dr. Pomp previously co-founded
GeneSeek, a global biotechnology company providing high-quality DNA
testing services to agribusiness and veterinary medicine that was
acquired by Neogen in 2010. He is an active angel investor, serves as a
member of the Advisory Board for AgriCapital, a boutique investment bank
in NYC, and sits on the Scientific Advisory Board for Locus Biosciences
and the Board of Directors for the Center for Entrepreneurial
Development. He is currently a Professor in the Departments of Genetics
(School of Medicine) and Nutrition (School of Public Health) at the
University of North Carolina – Chapel Hill.

Dr. Pomp said, “The CoreBiome
platforms represent a dramatic increase in the amount of information
researchers can get out of a microbiome study. This is already changing
the way microbiome screening is performed in a wide range of
applications. I am looking forward to working with the team in
leveraging these powerful technologies.”

The CoreBiome Board is chaired by Dr. Pamela York, an advisor and
university life science startup expert, currently General Partner of
Capita3. “We are delighted to have Daniel join the Board,” said Dr.
York. “His successes in the genomics and agriculture industries, along
with his history of building and investing in early stage companies,
will be instrumental in positioning CoreBiome for growth and strategic

co-founder and CEO Dan Knights stated, “This is an important step toward
being the globally trusted partner in microbiome research and
development. With the addition of Dr. Pomp to the Board of Directors,
CoreBiome continues to build out the roster of trusted advisors to
achieve its mission of enabling faster and smarter discovery of
microbiome therapeutics and diagnostics.”

About CoreBiome:
CoreBiome is a genomics platform company
focused on accelerating discovery for customers in the pharmaceutical,
agriculture, and research communities, to unleash the translational
potential of the microbiome. The Company’s proprietary BenchMarkTM,BoosterShotTM, BoostArrayTM, and Core
AnalysisTM platforms provide fast and information-rich
characterizations of microbial diversity and function, paired with
machine learning and expert analytics. For more information about
CoreBiome, visit


Neal Shea